114 results
Page 5 of 6
6-K
EX-99.1
5yyouqxl ha
7 May 19
RedHill Biopharma Submits New Drug Application for Talicia® for H. pylori Infection
6:06am
6-K
EX-99.1
xkks1p
4 Mar 19
Current report (foreign)
8:03am
6-K
EX-99.1
aznbnvf6u2ijtc h56e
26 Feb 19
RedHill Biopharma Provides Full-Year 2018 Financial Results and Operational Highlights
7:00am
6-K
EX-99.1
m0fqwr8ds7n
17 Jan 19
RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection
8:00am
424B5
coq0x0rcbnbsc 1hiifh
10 Dec 18
Prospectus supplement for primary offering
12:03pm
424B5
5fn nvyg1hticu9
4 Dec 18
Prospectus supplement for primary offering
4:05pm
6-K
EX-99.1
4kzmvefl6ta
3 Dec 18
RedHill Biopharma Announces Positive Top-Line Results from Confirmatory Phase 3 Study with TALICIA® for H. pylori Infection
7:01am
6-K
EX-99.1
dzcn3hul
29 Oct 18
Current report (foreign)
7:00am
6-K
EX-99.1
yooi7 ucwxvce
24 Oct 18
RedHill Biopharma Announces Final Patient Assessed in Confirmatory Phase III Study with TALICIA® for H. pylori Infection
8:01am
424B5
hze148a8v8nhbh8v6zmi
10 Aug 18
Prospectus supplement for primary offering
9:04am
424B5
1iq9xmm1to6xp 8w
9 Aug 18
Prospectus supplement for primary offering
6:58am
6-K
EX-99.1
dfy9frtzg6tg
25 Jul 18
Current report (foreign)
8:00am
6-K
EX-99.1
9rl0w
28 Jun 18
Current report (foreign)
9:00am
424B5
hjm49m8cty xhz
23 Dec 16
Prospectus supplement for primary offering
12:00am
424B5
9dt593egshdnv
23 Dec 16
Prospectus supplement for primary offering
12:00am